PROCEPT BioRobotics Faces Shareholder Lawsuit Over Sales Allegations

The complaint alleges that PROCEPT BioRobotics utilized aggressive discounting to create a surplus of U.S. handpiece units, a strategy that reportedly masked the company's actual operational performance. By pushing products into distribution channels beyond consumer demand, the company allegedly exposed itself to significant financial and operational risks that were not properly disclosed to the public.

According to the court filing, these actions rendered the company's business statements materially false and misleading. The Shareholders Foundation is now calling on affected investors to review their legal options regarding the recovery of losses. While the foundation is facilitating outreach to those who held stock during the period in question, it clarifies that it operates as a portfolio monitoring service rather than a law firm.